Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
出版年份 2022 全文链接
标题
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
作者
关键词
COVID-19, Type 2 diabetes mellitus, Antidiabetic medication
出版物
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 131, Issue -, Pages 155196
出版商
Elsevier BV
发表日期
2022-04-01
DOI
10.1016/j.metabol.2022.155196
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Clinical Characteristics and Risk Factors of Severe COVID-19
- (2021) Jianhua Hu et al. GERONTOLOGY
- Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study
- (2021) Tak Kyu Oh et al. ACTA DIABETOLOGICA
- Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients With Type 2 Diabetes
- (2021) Yunha Noh et al. DIABETES CARE
- Comparable COVID ‐19 outcomes with current use of GLP ‐1 receptor agonists, DPP ‐4 inhibitors or SGLT ‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV ‐2
- (2021) Simone Bastrup Israelsen et al. DIABETES OBESITY & METABOLISM
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID‐19: A Retrospective Study
- (2021) Shuai Yuan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes
- (2021) Jingya Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis
- (2021) B. M. Bonora et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul
- (2021) Ilhan Satman et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
- (2021) Sabrina Schlesinger et al. DIABETOLOGIA
- Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19
- (2021) Jose Manuel Ramos-Rincón et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
- (2021) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
- (2021) Anna R. Kahkoska et al. DIABETES CARE
- The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
- (2021) Wenxing Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa
- (2021) Joel A. Dave et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review
- (2021) Megan M. Kristan et al. Endocrine Practice
- Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study
- (2021) Xueqi Cheng et al. LIFE SCIENCES
- DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis
- (2021) Yan Yang et al. PLoS One
- Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
- (2021) Rodrigo Esaki Tamura et al. Diabetology & Metabolic Syndrome
- Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
- (2021) Elizabeth Varghese et al. PLoS Pathogens
- Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
- (2021) Rifat Emral et al. Diabetes Therapy
- Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States
- (2021) Kristina S. Boye et al. Diabetes Therapy
- Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
- (2021) Chengxia Kan et al. Frontiers in Endocrinology
- Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism
- (2021) Tahmina Nasrin Poly et al. Journal of Clinical Medicine
- Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies
- (2021) Dimitrios Patoulias et al. Endocrinology and Metabolism
- Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
- (2021) Jennifer E. Nyland et al. DIABETES
- Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
- (2021) Pandora L. Wander et al. DIABETES CARE
- From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression
- (2021) Carlo Bruno Giorda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Factors influencing on development of COVID-19 pneumonia and association with oral anti-diabetic drugs in hospitalized patients with diabetes mellitus
- (2021) Ayça Elibol et al. Primary Care Diabetes
- Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study
- (2021) Shun-Kui Luo et al. World Journal of Diabetes
- Association Between Metformin Use and Mortality Among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection
- (2021) Angeli Nicole Ong et al. Journal of the ASEAN Federation of Endocrine Societies
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Exposure to DPP ‐4 inhibitors and COVID ‐19 among people with type 2 diabetes. A case–control study
- (2020) Gian Paolo Fadini et al. DIABETES OBESITY & METABOLISM
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
- (2020) Yongli Yan et al. BMJ Open Diabetes Research & Care
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
- (2020) Shivani Agarwal et al. DIABETES CARE
- Metformin in COVID-19: A possible role beyond diabetes
- (2020) Swati Sharma et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
- (2020) Bo Wang et al. Journal of Hematology & Oncology
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
- (2020) Marco Mirani et al. DIABETES CARE
- Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
- (2020) Rocky Strollo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis
- (2020) Chia Siang Kow et al. JOURNAL OF MEDICAL VIROLOGY
- Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
- (2020) Michelle Lally et al. Journal of the American Medical Directors Association
- Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily
- (2020) Silverii Giovanni Antonio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
- (2020) Luis M. Pérez-Belmonte et al. BMC Medicine
- COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
- (2020) Harald Sourij et al. DIABETES OBESITY & METABOLISM
- Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19
- (2020) Shayan Riahi et al. ENDOCRINE RESEARCH
- Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
- (2016) Young-Sun Lee et al. MEDIATORS OF INFLAMMATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now